Two cheques a day apart, almost the same amount, two opposite directions. On 15 July, Walden Robotics emerged from stealth with $300 million, valuing the company at $1.1 billion. On the 16th, Hyundai signed for $325 million to buy from SoftBank the 9.65% stake it still lacked in Boston Dynamics. One is entering, the other is leaving. What separates the two deals comes down to one line in Walden’s press release: since February, its robots have been working in production at a Toyota factory.
What SoftBank is selling is not what people think
SoftBank’s exit is not a whim, nor is it a bet gone wrong. It is a clause. The 2021 agreement included a put option allowing SoftBank to sell its stake at a pre-agreed price if Boston Dynamics was not listed that year. It is not listed; the option is exercised. Hyundai had taken an 80% stake in 2021 in a deal valuing the whole at around $1.1 billion, before successive capital increases diluted SoftBank’s share to around 10%. Five years later, the company is worth around $3.3 billion and Hyundai owns it entirely, Atlas programme included. Tripling in value over five years is not a failure. But it is the trajectory of a laboratory asset, not that of a supplier.
What Toyota is buying is access to the workshop
Walden is eighteen months old and six months into public life. Russ Tedrake, a professor at MIT, spent ten years at the Toyota Research Institute as Senior Vice President of large behaviour models before spinning out the company from the laboratory in January. The round is co-led by Toyota and Deviation Capital, with NVIDIA, Boeing, Samsung Ventures, Prologis Ventures and CoreWeave Ventures in the wagon. What this money buys is not a demonstration: since February, Walden’s robots have been doing useful work in production at a Toyota factory in North America, alongside human operators. The company claims less than two months between the first pilot and real production. Toyota is not just funding a supplier; it is opening its line to it—and it is this openness, far more than the chequebook, that is rare.
The word Walden never writes
A detail that is not one: Walden’s official press release does not contain the word “humanoid” a single time. It speaks of general-purpose robots, of versatile robots. The word appeared in press coverage, not in the company’s own mouth. This is not a communicator’s modesty; it is an indication of what is being sold: not a two-legged silhouette, but the ability to be assigned to a post.
The metric of the week is therefore neither an amount nor a valuation, but a ratio. Five months of real production with a manufacturer weighs in at $1.1 billion. Fifteen years of fundamental research, several generations of Atlas and the finest catalogue of videos in the discipline weighs in at $3.3 billion. Adjusted for the time elapsed, the second asset has become the cheaper of the two. Three weeks ago, we wrote here that the stock market was crowning humanoids before they had proved they could stand up. This week, the order has reversed: money arrives after proof, and proof is called a workstation.